Assertio (ASRT) Expected to Announce Earnings on Monday

Assertio (NASDAQ:ASRT - Get Free Report) is expected to issue its Q1 2025 quarterly earnings data before the market opens on Monday, May 5th. Analysts expect Assertio to post earnings of ($0.03) per share and revenue of $27.52 million for the quarter.

Assertio Stock Performance

NASDAQ ASRT opened at $0.62 on Monday. The company has a fifty day moving average of $0.70 and a two-hundred day moving average of $0.84. The company has a market capitalization of $59.19 million, a PE ratio of -0.85, a P/E/G ratio of 3.25 and a beta of 0.56. Assertio has a 1 year low of $0.51 and a 1 year high of $1.80. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.01 and a quick ratio of 1.57.

Analysts Set New Price Targets

ASRT has been the topic of a number of research reports. HC Wainwright dropped their price target on Assertio from $4.00 to $3.50 and set a "buy" rating on the stock in a research note on Wednesday, March 19th. StockNews.com raised shares of Assertio from a "hold" rating to a "buy" rating in a report on Monday, April 14th. Finally, Industrial Alliance Securities set a $1.75 price target on shares of Assertio in a research note on Friday, March 14th.

Assertio Company Profile

Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.